Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
EverCommerce Inc. (NASDAQ: EVCM) President Matthew David Feierstein executed a sale of 1,971 shares on July 9, 2026, totaling $19,761. The transaction occurred at prices between $10.00 and $10.09 per share, with a weighted average of $10.0261. This sale follows a first-quarter earnings report that revealed a significant miss on earnings per share (…
William Chad Lenamon, Executive Vice President and Chief Operating Officer at Kodiak Gas Services, Inc. (NASDAQ:KGS), sold 1,000 shares of company stock on July 13, 2026, generating proceeds of $67,790. The transaction was executed at $67.79 per share through a 10b5-1 trading plan established on March 13, 2026. Following the sale, Lenamon retains d…
Michael Anthony Loh, a director at Butler National Corp. (NASDAQ: BUKS), recently acquired 3,658 shares of the company's common stock, according to a Securities and Exchange Commission filing. The transaction occurred on July 10, 2026, with shares purchased at $4.34 each. This insider buying activity comes as Butler National reports its strongest f…
Block, Inc. (NASDAQ: XYZ) director Anthony Mathew Eisen has completed a series of stock sales totaling approximately $1.4 million, executed under a pre-existing trading arrangement. The transactions, which occurred in mid-July 2026, reduce his direct holdings in the company while the broader financial services sector monitors Block's strategic shif…
Brent M. Stevens, a director and ten percent owner of Concrete Pumping Holdings, Inc. (NASDAQ:BBCP), recently executed a series of stock sales totaling approximately $1,082,976. The transactions, which occurred over two consecutive days in July 2026, reduce his direct shareholding while the company’s stock has appreciated significantly over the pas…
Silver Lake Technology Investors IV, L.P., an entity affiliated with the private equity firm Silver Lake Group, has executed the sale of 1,332 shares of Dell Technologies Inc. (NASDAQ:DELL) Class C Common Stock. The transaction, valued at $604,114, was recorded on July 9, 2026, occurring after a period of significant appreciation for the technology…
Michelle Chang, Chief Financial Officer of Zoom Communications, Inc. (NASDAQ:ZM), executed a sale of 8,489 shares of Class A Common Stock totaling $770,819 on July 10, 2026. The transaction was conducted under a Rule 10b5-1 trading plan established on June 13, 2025. The sale occurred near the stock's current trading price of $91.88. Zoom maintains …
Entities affiliated with Silver Lake Partners and Dell Technologies director Egon Durban executed the sale of approximately $15.8 million in Class C Common Stock on July 9, 2026. The transaction followed the conversion of Class B shares into Class C shares, a mechanism allowing holders to liquidate equity without regulatory restrictions on direct C…
Silver Lake Group, L.L.C., alongside Dell Technologies director Egon Durban and related affiliated entities, executed a series of sales involving Dell Technologies Inc. Class C Common Stock, realizing approximately $26.98 million in value. These transactions, recorded on July 9, 2026, involved the disposal of 59,892 shares at weighted average price…
Entities linked to Silver Lake and Dell Technologies Inc. (NYSE:DELL) director Egon Durban executed a sale of 600 shares of Dell Technologies Class C Common Stock on July 9, 2026, generating $272,578 in proceeds. The divestment follows a conversion of Class B shares into Class C shares and occurs amidst a 260% stock surge over the past six months. …
Entities tied to Silver Lake, including Dell director Egon Durban, executed a $31.1 million sale of Dell Technologies Inc. (NASDAQ:DELL) Class C Common Stock on July 9, 2026. The transactions followed a structural conversion of Class B shares into Class C, highlighting ongoing capital adjustments within the firm's holdings. This activity occurs aga…
Juan C. Jaen, President of Arcus Biosciences (NASDAQ:RCUS), completed the sale of 68,569 shares over two days in July 2026, generating approximately $2.03 million. The transactions were executed via a Rule 10b5-1 trading plan, a mechanism designed to allow insiders to trade shares according to a predetermined schedule. This activity follows a signi…
Charles H Giancarlo, serving as both Chief Executive Officer and a board director at Everpure, Inc. (NASDAQ:P), has completed a series of equity transactions totaling approximately $10.9 million. The divestitures occurred across two consecutive trading days in early July 2026, with shares changing hands at prices between $80.00 and $82.50. All sale…
Windacre Partnership Master Fund, LP, a significant institutional investor in Perimeter Solutions, Inc. (NASDAQ: PRM), has executed a substantial divestment of its holdings in the fire retardant manufacturer. The fund sold approximately $195.6 million worth of ordinary shares between June 26 and June 30, 2026. This transaction occurs as the stock h…
Director Susan J.S. Taylor executed a significant equity sale in Everpure, Inc. (NASDAQ:P) on July 9, 2026, divesting 8,543 shares at $81.74 per share. The transaction, valued at $698,304, occurs as the stock trades below the sale price, reflecting a complex dynamic between insider activity and broader market valuation metrics. This move follows a …
Neil Almstead, PTC Therapeutics' Chief Technical Operations Officer, executed a series of transactions on July 9, 2026, involving the exercise of stock options and the subsequent sale of 2,464 shares. The transactions were conducted under a Rule 10b5-1 plan established in November 2025. The sale occurred as the stock traded near its 52-week high, w…
PTC Therapeutics director Mary L. Smith executed a series of transactions on July 9, 2026, selling 15,834 shares valued at approximately $1.43 million. The sales followed the exercise of stock options on the same date, all conducted under a pre-arranged Rule 10b5-1 trading plan established in November 2025. This activity occurs against a backdrop o…
Kevin J. Mitchell, Executive Vice President and Chief Financial Officer at Phillips 66 (NYSE: PSX), executed a significant stock transaction on July 9, 2026, selling 11,021 shares for a total value of $2,094,285. The sale was facilitated through the exercise of employee stock options, which were granted under a vesting schedule that began on Februa…
Arjun Agarwal, Senior Vice President of Finance at Oruka Therapeutics, Inc. (NASDAQ: ORKA), executed a significant sale of company stock on July 13, 2026, following the exercise of employee stock options on the same day. The transactions occurred as the biotech firm's shares trade near a 52-week high, reflecting a substantial one-year gain, while a…
Ryan Savitz, Executive Vice President, Chief Financial Officer, and Chief Business Officer of Dianthus Therapeutics, Inc. (NASDAQ:DNTH), executed a series of transactions involving the sale of 31,249 shares of common stock on July 9, 2026, totaling approximately $3.16 million. The sales were conducted under a Rule 10b5-1 trading plan adopted on Dec…
Todd Dzyak, Chief Operating Officer of WidePoint Corporation, executed a sale of 5,000 shares of the company's common stock on July 9, 2026. The transaction was valued at $63,750, with each share sold at $12.75. This divestment reduces Dzyak's direct holdings to 110,436 shares. The sale comes as WidePoint reports improved Q1 2026 financial results,…
Michael George Rosenbaum, Chief Executive Officer of Guidewire Software, Inc. (NASDAQ:GWRE), sold 1,200 shares of the company's common stock on July 13, 2026. The transaction, valued at $166,164, was executed automatically under a 10b5-1 trading plan adopted on October 14, 2025. Following the sale, Rosenbaum directly holds 194,976 shares. The sale …
BridgeBio Pharma, Inc. (NASDAQ: BBIO) director Andrea Ellis executed a sale of $1,442,028 in company stock on July 9, 2026. The transaction, covering 17,167 shares at $84.00 per share, was conducted under a pre-established Rule 10b5-1 plan adopted in December 2025. This sale coincides with a period of significant corporate activity for BridgeBio, i…
Wilfred T. O’Gara, a director at LSI Industries Inc. (NASDAQ:LYTS), executed a significant divestment of 10,369 common shares on June 1, 2026, realizing approximately $249,789. This transaction reduces his direct holdings, including a joint account with his spouse, to 103,686 shares. The sale occurs against a backdrop of strong operational performa…
Richard McCathron, Chief Executive Officer of Hippo Holdings Inc. (NASDAQ: HIPO), executed a sale of 5,000 shares of common stock on July 9, 2026, generating proceeds of $142,650. The transaction, priced at $28.53 per share, was conducted under a Rule 10b5-1 trading plan established on August 29, 2025. Following the sale, McCathron retains a direct…
